Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading ->
Measurable outputs are a key element of the World Health Organization transformation and its “triple billion” target. Last week, WHO Executive Board discussed the Impact Framework, a key measurement system. Board members asked clarifications on indicators and underlined the challenge of data collection in many countries. A consultation with country experts is expected to be held before the May World Health Assembly. Continue reading ->
Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property, health, technology transfer, investment policy and especially their impact on developing countries. He has authored several books and academic articles and been a visiting professor at several universities. Additionally, he has consulted with many United Nations agencies, the World Bank, and other regional and international organisations and has advised several governments on intellectual property, innovation policy and public health. Correa was a member of the UK Commission on Intellectual Property, of the Commission on Intellectual Property, Innovation and Public Health established by the World Health Assembly and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture. Currently, he is the Director of the Centre for Interdisciplinary Studies on Industrial Property and Economics Law, at the University of Buenos Aires. He takes over as the Executive Director of the Secretariat of the Geneva-based South Centre from 1 July 2018. Correa recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is number two of two. The first, with Dr Othoman Mellouk, is available here.] Continue reading ->
A hundred years ago, the Spanish flu infected a third of the world population, and killed more people than the two world wars combined. The World Health Organization is seeking to help the world prepare for the next pandemic, which they say, is only waiting to happen. The recent World Health Assembly agreed to ask the WHO to complete an analysis on the implications of including seasonal influenza virus and pandemic virus genetic information into its benefit-sharing mechanism to help the world face the next influenza pandemic. Separately, the UN Convention on Biological Diversity (CBD) issued a study on how to handle virus genetic information, and voiced preference for publicly accessible databases for sharing this information, rather than public domain databases, as the latter raise issue of traceability of the information from originators and also from users. And a WHO official issued a call for WHO member states to become involved in activities of the CBD's Nagoya Protocol on access and benefit-sharing to ensure health priorities are put before environmental priorities on genetic resources. Continue reading ->
Goal 3 of the United Nations Sustainable Development Goals (SDGs) is to “ensure healthy lives and promote well-being for all at all ages.” Around the world, there are still children that experience malnutrition leading to stunting, low birth weight, overweight and wasting. Also, there are children who are less breastfed and mothers with anaemia. But countries at the annual World Health Assembly (WHA) last week agreed to continue work towards improving maternal, infant and young child nutrition as well as put an end to all forms of malnutrition by 2030. Continue reading ->
The World Health Assembly this week agreed on a roadmap to be designed by the World Health Organization in consultation with member states to facilitate access to medicines and vaccines, including actions and activities for the period 2019-2023. If everyone agrees access to medicines and vaccines is indispensable for universal health coverage, views are still divided when it comes to intellectual property rights. The ranks of strong proponents of IP resulting in high prices are however thinning. The United States remains unshakeable, criticising compulsory licences used by countries to ensure affordable medicines are available. Continue reading ->
A week after African ministers of health adopted a treaty for the establishment on the African Medicines Agency, an international conference held on the side of the World Health Assembly denounced the rampant and increasing issue of fake medicines in Africa, and the lack of adequate action and political will. The Benin president said Benin's efforts to fight traffickers is so far unsupported, and called developed countries to commit to the fight. Other speakers insisted on the importance of local production of medicines, and the need for biting legislation to defeat fake medicines. Continue reading ->
The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments. Continue reading ->